Nikolaj Christian Torp

Medicine and Dentistry

1. Alcohol-Related Liver Disease 100%
2. Liver Disease 60%
3. Fibrosis 45%
4. Liver Fibrosis 45%
5. Nonalcoholic Fatty Liver 43%
6. Alcohol Consumption 38%
7. Prospective Cohort Study 31%
8. Liver Cirrhosis 28%
9. Binge Drinking 25%
10. Ascites 25%
11. Alcohol Intoxication 21%
12. Transient Elastography 20%
13. Fibrogenesis 17%
14. Placebo 16%
15. Randomized Controlled Trial 14%
16. Biological Marker 13%
17. Human Albumin 12%
18. Lipid Metabolism 12%
19. Maturity Onset Diabetes of the Young 12%
20. Low Fat Diet 12%
21. Lipidomics 12%
22. Rifaximin 12%
23. Lifestyle Modification 12%
24. Non-Alcoholic Fatty Liver Disease 12%
25. Transplantation 12%
26. Infection 12%
27. High Fat Food 12%
28. Hazard Ratio 12%
29. Fatty Acid 11%
30. Clinical Trial 10%
31. Chronic Liver Disease 9%
32. Extracellular Matrix 9%
33. Secondary Care 9%
34. Primary Health Care 9%
35. Venous Blood 9%
36. Systemic Circulation 8%
37. FGF21 8%
38. Lysophosphatidylcholine 8%
39. Disease 7%
40. Adverse Event 7%
41. Odds Ratio 7%
42. Triacylglycerol 6%
43. Screening Test 6%
44. Abstinence 6%
45. Intention-to-Treat Analysis 6%
46. All Cause Mortality 6%
47. Alcohol 5%
48. Liver Biopsy 5%
49. Metabolic Dysfunction-Associated Steatotic Liver Disease 5%
50. Risk Stratification 5%